Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients
PHASE2CompletedINTERVENTIONAL
Enrollment
40
Participants
Timeline
Start Date
June 30, 2005
Study Completion Date
December 31, 2007
Conditions
HIV Infections
Interventions
DRUG
Kaletra
Trial Locations (1)
77004
Therapeutic Concepts, P.A., Houston
All Listed Sponsors
lead
Therapeutic Concepts
OTHER
NCT00116636 - Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients | Biotech Hunter | Biotech Hunter